VanEck Biotech ETF (NASDAQ:BBH) Trading Down 1.2% – Here’s What Happened

VanEck Biotech ETF (NASDAQ:BBH)’s stock price traded down 1.2% on Monday . The stock traded as low as $185.74 and last traded at $185.74. 3,478 shares were traded during trading, a decline of 21% from the average session volume of 4,399 shares. The stock had previously closed at $188.00.

VanEck Biotech ETF Trading Down 1.2%

The company has a fifty day moving average of $186.80 and a two-hundred day moving average of $190.74.

Institutional Trading of VanEck Biotech ETF

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Empowered Funds LLC purchased a new stake in VanEck Biotech ETF in the fourth quarter worth $38,000. Flagship Harbor Advisors LLC purchased a new position in shares of VanEck Biotech ETF during the fourth quarter valued at $47,000. Allworth Financial LP increased its stake in shares of VanEck Biotech ETF by 255.0% during the fourth quarter. Allworth Financial LP now owns 426 shares of the company’s stock valued at $81,000 after buying an additional 306 shares during the period. Fifth Third Bancorp purchased a new position in shares of VanEck Biotech ETF during the first quarter valued at $127,000. Finally, Huntington National Bank purchased a new position in shares of VanEck Biotech ETF during the fourth quarter valued at $132,000. Hedge funds and other institutional investors own 32.05% of the company’s stock.

VanEck Biotech ETF Company Profile

The BIOTECH HOLDING COMPANY DEPOSITARY RECEIPTS or HOLDRS TRUST was formed under the depositary trust agreement, among The Bank of New York, as trustee, Merrill Lynch, Pierce, Fenner & Smith Incorporated, other depositors and the owners of the Biotech HOLDRS. The trust currently holds shares of common stock or American depositary shares issued by a group of companies that were, at the time of the initial offering, generally considered to be involved in various segments of thebiotechnology industry.